Cystatin-C C-guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project

NCT02945241 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

399

Enrollment

OTHER

Sponsor class

Conditions

Methicillin-resistant Staphylococcus Aureus
Sepsis
Critical Illness

Interventions

DRUG: Vancomycin
OTHER: Cystatin C dosing algorithm
OTHER: Creatine clearance dosing algorithm

Sponsor

Mayo Clinic